🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Oncology HERE & NOW Webcast (GU Oncology) Upper Tract Urothelial Carcinoma Bárbara Melão, MD, PhD 🇧🇷 and Dr. Philippe Spiess Philippe spiess 🇺🇸 OncoAlert 🚨 🍏 Apple Podcasts 👉podcasts.apple.com/se/podcast/onc… VJ Oncology high5md COR2ED

The #ASCO25 abstracts I cannot wait to see!

Our OncoAlert list of Top 10 GI abstracts ASCO 👇

Need a quick wrap-up of the latest in GI Oncology just in time for #ASCO25? youtu.be/fcM-Rw5Zg2g?si… Want it delivered by some of the top experts in the field? 🚨 You're invited to join us for concise 15-minute presentations, each focused on a specific tumor group—perfect for a

Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2–Low Metastatic #BreastCancer ascopubs.org/doi/abs/10.120… This study evaluated the cost-effectiveness of treatment sequences for 🧬HER2-low metastatic breast cancer using a decision model based on

Factors associated with switching from active surveillance to treatment in men with low-risk prostate cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… This population-based study examined factors influencing the decision to transition from active surveillance (AS) to definitive treatment among

Navigating 🧭 #earlycareer can be a challenge, but finding one's passion 🔥 is well worth it. Join us on Friday May 30th at #ASCO25 at 2:45p CST as we each share our stories from #community, #academia and #industry perspectives in room E350 🔗: meetings.asco.org/2025-asco-annu…

The #ASCO25 #OncoAlertTOP10 Abstracts in #GUOncology These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸 #ProstateCancer #BladderCancer #kidneyCancer ⭐Abs 4518 SURE-02: NEOADJUVANT SACITUZUMAB GOVITECAN PLUS

Please check our Top10 picks for GU abstracts at #ASCO25 ASCO OncoAlert

Do not Miss the opportunities to Connect with ⁦Journal of Clinical Oncology⁩ Editors and discuss meeting content or career opportunities #ASCO25 ⁦ASCO⁩ JCO Central - ASCO Meeting Room S403b ⁦OncLive.com⁩ ⁦OncoAlert⁩ ⁦UroToday.com⁩ ⁦Medscape⁩ asco.org/annual-meeting…

Age and comorbidity in relation to treatment and survival outcomes in triple-negative breast cancer: A Swedish nationwide registry-based study geriatriconcology.net/article/S1879-… William Dale, MD, PhD, FASCO Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #CharlsonComorbidityIndex

Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node metastasis which is comparable to stage IIIC SGO IGCS ESGO ASCO OncoAlert sciencedirect.com/science/articl…

The dual capacity for cancers to metastasize and resist systemic treatment is the tipping point for driving lethal cancer. Drs. Pienta, Goodin & Amend explore how eco-evolutionary principles can guide new interventions: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Kenneth Pienta Sarah R. Amend, Ph.D. OncoAlert

Don’t miss our #MASCC25 workshop “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment”, chaired by Maryam Lustberg MD, MPH, FASCO & Tingting Zhang Learn more: mascc.org/annualmeeting2… #SuppOnc Stacey Tinianov (she/her) MPH, BCPA OncoAlert

📑The #ABC8 programme is available online. 🔔Do not miss the session on improving quality of life for ABC patients! 🗓️When: Friday 7th Nov 🔗More information and registration at abc-lisbon.org OncoAlert #ABClisbon

📙Treatment of metastatic gastric/GEJ adenoca Journal of the @NCCN ✅A simple very nice algorithm 👉doi.org/10.6004/jnccn.… OncoAlert Dr Joseph McCollom DO #cancer #oncology #MedX #gastric

ERRATUM⭐️ ABSTRACT #LBA5006 should be the Phase 3 AMPLITUDE trial: Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) patients (pts) with alterations in homologous recombination repair (HRR) genes.

Looking forward to another fantastic ASCO meeting! Would add to this list the Javelin Medley trial by Jean Hoffman-Censits et al. on Sunday AM session after Michiel van der Heijden CM901! Interesting data in advanced urothelial Ca! Shilpa Gupta Neeraj Agarwal, MD, FASCO Fred Hutch Cancer Center Nicole D. Fleming MD OncoAlert

Great tips Cristiane D Bergerot #ASCO25 ASCO OncoAlert